Related Experiment Videos
Reversal of diastolic dysfunction by intravenous magnesium chloride
Insights
Intravenous magnesium chloride effectively treated diastolic dysfunction in coronary artery disease patients by significantly reducing left ventricular end-diastolic pressure. Further research is needed to confirm long-term benefits.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Diastolic dysfunction is a common complication in patients with coronary artery disease (CAD).
- Elevated left ventricular end-diastolic pressure (LVEDP) is a key indicator of diastolic dysfunction.
Purpose of the Study:
- To investigate the efficacy of magnesium chloride in treating diastolic dysfunction in patients with CAD.
- To assess the impact of magnesium chloride on LVEDP in this patient population.
Main Methods:
- An open study involving intravenous injection of 5 mL of 17% magnesium chloride solution (100 mg elemental magnesium).
- The intervention was administered during routine coronary angiography in ten patients with angiographically documented CAD and elevated LVEDP.
- Measurements of LVEDP were taken before and after magnesium chloride administration.
Main Results:
- Magnesium chloride injection resulted in a significant reduction in LVEDP in all patients.
- The mean LVEDP decreased from 24 +/- 3 mmHg to 16 +/- 3 mmHg (P < 0.001).
Conclusions:
- Intravenous magnesium chloride effectively improved left ventricular diastolic function in the short term for patients with CAD.
- The findings suggest magnesium chloride as a potential therapeutic agent for diastolic dysfunction in CAD.
- Further studies are warranted to evaluate the long-term effects and clinical significance of this treatment.
Objective:
To treat diastolic dysfunction in patients with coronary artery disease (CAD).
Design:
Open study of the intravenous injection of 5 mL of a solution containing 17% magnesium chloride (equal to 100 mg of elemental magnesium) during routine coronary angiography in patients with a raised left ventricular end-diastolic pressure (LVEDP).
Setting:
A hospital department of cardiac hemodynamics.
Subjects:
Ten patients with angiographically documented CAD.
Results:
After magnesium chloride injection, the LVEDP was significantly reduced in all patients, from a mean of 24 +/- 3 to 16 +/- 3 mmHg (P < 0.001).
Conclusions:
Under the short term conditions of the study, the injection of magnesium chloride effectively improved left ventricular diastolic function. Further study of the long term effect is required.